{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:58:38Z","timestamp":1792277918355,"version":"4.4.0"},"reference-count":26,"publisher":"Massachusetts Medical Society","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2023,12,7]]},"DOI":"10.1056\/nejmoa2309169","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T17:01:20Z","timestamp":1701882080000},"page":"2162-2174","source":"Crossref","is-referenced-by-count":506,"title":["Mirvetuximab Soravtansine in FR\u03b1-Positive, Platinum-Resistant Ovarian Cancer"],"prefix":"10.1056","volume":"389","author":[{"given":"Kathleen N.","family":"Moore","sequence":"first","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Angelergues","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gottfried E.","family":"Konecny","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Banerjee","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Lorusso","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Yun","family":"Lee","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Moroney","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Colombo","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Roszak","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Tromp","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tashanna","family":"Myers","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Won","family":"Lee","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Beiner","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey M.","family":"Cosgrove","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cibula","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lainie P.","family":"Martin","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Sabatier","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Buscema","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purificaci\u00f3n","family":"Est\u00e9vez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Coffman","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibani","family":"Nicum","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda R.","family":"Duska","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Pignata","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"G\u00e1lvez","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemei","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Method","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Berkenblit","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Bello Roufai","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"Van Gorp","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Groupe Hospitalier Diaconesses\u2013Croix Saint Simon, Paris (A.A.), Aix-Marseille Universit\u00e9, INSERM, National Center for Scientific Research, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille (R.S.), and Institut Curie, Saint-Cloud (D.B.R.) \u2014 all in France; the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (G.E.K.); Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Universitat Aut\u00f2noma de Barcelona, Sabadell (Y.G.), Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla, Seville (P.E.-G.), and Hospital Universitario de Ja\u00e9n, Jaen (F.G.) \u2014 all in Spain; the Royal Marsden NHS Foundation Trust and Institute of Cancer Research (S.B.) and University College London Cancer Institute (S.N.) \u2014 both in London; Fondazione Policlinico Universitario Agostino Gemelli IRCCS..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2011.11.010"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3773"},{"key":"e_1_3_5_4_2","unstructured":"International Agency for Research on Cancer. Ovary. 2020 (https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/25-Ovary-fact-sheet.pdf)."},{"key":"e_1_3_5_5_2","unstructured":"National Cancer Institute. Cancer stat facts: ovarian cancer. Surveillance Epidemiology and End Results Program. 2023 (https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html)."},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00251"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071663"},{"key":"e_1_3_5_8_2","first-page":"45","article-title":"Update on first-line treatment of advanced ovarian carcinoma.","volume":"5","author":"Kemp Z","year":"2013","unstructured":"Kemp Z, Ledermann J. Update on first-line treatment of advanced ovarian carcinoma. Int J Womens Health 2013;5:45-51.23378788","journal-title":"Int J Womens Health"},{"key":"e_1_3_5_9_2","unstructured":"National Comprehensive Cancer Network. NCCN guidelines for ovarian cancer including fallopian tube cancer and primary peritoneal cancer. 2023."},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.08.032"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00334"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00216-3"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.4489"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.0197"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-1095"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.11.020"},{"key":"e_1_3_5_17_2","first-page":"3567","article-title":"Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue.","volume":"28","author":"Markert S","year":"2008","unstructured":"Markert S, Lassmann S, Gabriel B, et al. Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue. Anticancer Res 2008;28:3567-3572.19189636","journal-title":"Anticancer Res"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.08.015"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.9538"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01900"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.02.017"},{"key":"e_1_3_5_22_2","doi-asserted-by":"crossref","unstructured":"Coleman RL Oaknin A Pignata S et al. Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FR\u03b1) expression: evaluation of sequence of therapy on anti-tumor activity in the SORAYA study. Presented at the 2023 Society of Gynecologic Oncology Annual Meeting on Women\u2019s Cancer Tampa FL March 25\u201328 2023.","DOI":"10.1016\/j.ygyno.2023.06.468"},{"key":"e_1_3_5_23_2","unstructured":"Elahere (mirvetuximab soravtansine-gynx): prescribing information. Waltham MA: ImmunoGen November 2022 (https:\/\/www.elahere.com\/pdf\/prescribing-information.pdf)."},{"key":"e_1_3_5_24_2","unstructured":"Food and Drug Administration. BLA accelerated approval (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2022\/761310Orig1s000ltr.pdf)."},{"key":"e_1_3_5_25_2","doi-asserted-by":"crossref","unstructured":"Moore KN Oza AM Columbo N et al. FORWARD I (GOG 3011): a phase III study of mirvetuximab soravtansine a folate receptor alpha (FR\u03b1)-targeting antibody-drug conjugate versus chemotherapy in patients with platinum-resistant ovarian cancer. Presented at the European Society for Medical Oncology Congress Barcelona September 27\u2013October 1 2019.","DOI":"10.1093\/annonc\/mdz250"},{"key":"e_1_3_5_26_2","volume-title":"Ventana FOLR1 (FOLR1-2.1) RxDx assay","year":"2022","unstructured":"Ventana FOLR1 (FOLR1-2.1) RxDx assay. Tucson, AZ: Ventana Medical Systems, 2022 (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf22\/P220006C.pdf)."},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2023.101155"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2309169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:48:18Z","timestamp":1749667698000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2309169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":26,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023,12,7]]}},"alternative-id":["10.1056\/NEJMoa2309169"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2309169","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]}}}